Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3

BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bojarová, P., Tavares, M. R., Laaf, D., Bumba, L., Petrásková, L., Konefał, R., Bláhová, M., Pelantová, H., Elling, L., Etrych, T., Chytil, P., Křen, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146777/
https://www.ncbi.nlm.nih.gov/pubmed/30236114
http://dx.doi.org/10.1186/s12951-018-0399-1